Form 4: Cytokinetics Director Receives Stock Grant
Insider Transaction (Form 4)
Robert Arthur Harrington, a Director of Cytokinetics Inc, received 151 shares of common stock on July 15, 2026.
Summary
- Grant/award: acquired 151 Common Stock at $82.62 ($12,476) on July 15, 2026; holds 21,932 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert Arthur Harrington — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Common Stock | 151 | $83 | $12.5K | 21,932 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (151 shares) |
Keywords
insider transaction, Form 4, CYTK, CYTOKINETICS INC, neutral, Robert Arthur Harrington
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.